A Metabolic Enhancer Protects against Diet-Induced Obesity and Liver Steatosis and Corrects a Pro-Atherogenic Serum Profile in Mice

Objective: Metabolic Syndrome (MetS) affects hundreds of millions of individuals and constitutes a major cause of morbidity and mortality worldwide. Obesity is believed to be at the core of metabolic abnormalities associated with MetS, including dyslipidemia, insulin resistance, fatty liver disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Platko, Khrystyna, Lebeau, Paul F., Nederveen, Joshua P., Byun, Jae Hyun, MacDonald, Melissa E., Bourgeois, Jacqueline M., Tarnopolsky, Mark A., Austin, Richard C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221984/
https://www.ncbi.nlm.nih.gov/pubmed/37242292
http://dx.doi.org/10.3390/nu15102410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221984/
https://www.ncbi.nlm.nih.gov/pubmed/37242292
http://dx.doi.org/10.3390/nu15102410

Ejemplares similares